PT  - JOURNAL ARTICLE
AU  - Kurita, Junko
AU  - Sugishita, Yoshiyuki
AU  - Sugawara, Tamie
AU  - Ohkusa, Yasushi
TI  - Estimation of protection for COVID-19 in children from epidemiological information and estimate effect of policy in Japan
AID  - 10.1101/2020.03.27.20045252
DP  - 2020 Jan 01
TA  - medRxiv
PG  - 2020.03.27.20045252
4099  - http://medrxiv.org/content/early/2020/03/30/2020.03.27.20045252.short
4100  - http://medrxiv.org/content/early/2020/03/30/2020.03.27.20045252.full
AB  - Background Incidence in children was much less than in adults during the COVID-19 outbreak. Sports and entertainment events were canceled (VEC) in Japan for two weeks during 26 February – 13 March. Most schools were closed (SC).Object We construct a susceptible–infected–recovered model using three age classes and estimate the basic reproduction number (R0) and protection level among children simultaneously. Then we simulate SC and VEC effects.Method We used data of patients with symptoms in Japan during 14 January to assess SC and VEC introduction. Effects of SC and VEC were incorporated into the model through change in the contact pattern or frequencies among age classes.Results Results suggest R0 as 2.86 [95%CI of 2.73, 2.97]. The protection level was estimated as 0.4 [0.2, 0.7]. SC and VEC can reduce the total number of patients significantly, by 6–7%.Discussion and Conclusion The estimated R0 was similar to that found from other studies in China and Japan. We found a significant protection level among children, and by effects of SC and VEC. IntroductionCompeting Interest StatementThe authors have declared no competing interest.Funding StatementThe author(s) received no specific funding for this work.Author DeclarationsAll relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.YesAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesJapan Ministry of Health, Labour and Welfare. Press Releases of Domestic Situation (in Japanese) https://www.mhlw.go.jp/stf/seisakunitsuite/bunya/0000121431_00086.html